Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

Excess weight can trigger chronic low-grade inflammation, which has been linked to increased risk for conditions such as heart disease and dementia. GLP-1s work by suppressing appetite and making ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

G LP-1 drugs containing semaglutide (the active ingredient in Ozempic and Wegovy) have exploded in popularity for their ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced new findings from the SLIM LIVER study (also known as A5371). These data suggest that blood-based ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...